Neurotek. Consulta y laboratorio de Disautonomía

10/10/2025

04/09/2025

Los filamentos de cadena ligera pueden ser un buen biomarcador de daño axonal

A 𝐧𝐞𝐮𝐫𝐨𝐟𝐢𝐥𝐚𝐦𝐞𝐧𝐭 is an intermediate filament with three isoforms (light, medium, and heavy) that is expressed specifically in neurons. Neurofilaments form heteropolymers and are crucial constituents of the cytoskeleton, particularly in axons. During neuronal or axonal breakdown, neurofilaments are released extracellularly and can be measured in blood or cerebrospinal fluid as a biomarker of neurodegeneration.

28/08/2025

Is small fiber neuropathy linked to autoimmunity? Experts are divided: https://hubs.la/Q03G03QS0

28/08/2025

Cuidado con el calor en pacientes con dissutonomia especialmente si no sudan

Un extenso estudio en Taiwán revela que la exposición prolongada a olas de calor acelera el envejecimiento biológico de forma comparable al consumo de alcohol o al tabaquismo, con implicaciones inquietantes para la salud global.

27/08/2025

Neuropathic Pain and Distinct CASPR2 Autoantibody IgG Subclasses Drive Neuronal Hyperexcitability: https://hubs.la/Q03DfJt90

17/08/2025

The discovery of CRISPR/Cas9 genetic scissors has had a revolutionary impact on the life sciences. In the course of a few weeks, scientists can change the code of life with extremely high precision, making CRISPR/Cas9 one of gene technology’s sharpest tools.

This genetic tool has not only revolutionised basic science, but also resulted in innovative crops and will lead to ground-breaking new medical treatments.

The use of CRISPR/Cas9 has exploded since its discovery in 2012. In medicine, clinical trials of new cancer therapies are underway, and the dream of being able to cure inherited diseases is about to come true.

Learn more: https://www.nobelprize.org/prizes/chemistry/2020/summary/

15/08/2025

Mensaje importante

13/08/2025

El virus de Epstein Barr está relacionado a largo plazo con neoplasias y enfermedades autoinmunes, algunas con disautonomia….el desarrollo de una vacuna sería un gran avance terapéutico

No FDA-approved vaccine exists for Epstein-Barr virus (EBV), which causes infectious mononucleosis, commonly known as mono, and is associated with multiple autoimmune diseases and several types of cancer. NIH has launched a clinical trial of a new vaccine candidate designed to prevent EBV infection. The vaccine aims to produce antibodies to protect certain types of cells from becoming infected, including those that line the throat. This is important because EBV is usually transmitted by infected saliva that enters the throat of an uninfected person. The study team is conducting the trial at the NIH Clinical Center in Bethesda, Maryland. Learn more: https://clinicaltrials.gov/study/NCT06908096

08/08/2025

El litio puede ser una opcion terapeutica en Alzheimer

Replenishing the brain’s natural stores of lithium can protect against and even reverse Alzheimer’s disease

07/08/2025

01/05/2025

In recognition of , Dysautonomia International invites you to join us on Thursday, May 15th at 7:00PM Eastern for a free webinar on biomechanics, Ehlers-Danlos syndromes and the autonomic nervous system including evaluation, treatment and influencing factors, presented by Dr. Alissa Zingman, founder of P.R.I.S.M. Register for free at: bit.ly/EDS_ANS_biomechanics

Everyone who registers for this webinar will be sent a recording of the content a few weeks after the webinar has concluded, even if you can't join us for the live broadcast. Dr. Zingman will take questions from the audience during the live broadcast.

13/04/2025